EMILY BUXTON brings light and life to an organization. She adapts easily to situations and environments, stays close to people at all levels in an organization, and builds and develops engaged and passionate teams. An intuitive thinker with a gift for reading situations correctly, she makes decisions quickly, communicates directly, and calls the tough ones with integrity.
EMILY BUXTON brings light and life to an organization. She adapts easily to situations and environments, stays close to people at all levels in an organization, and builds and develops engaged and passionate teams. An intuitive thinker with a gift for reading situations correctly, she makes decisions quickly, communicates directly, and calls the tough ones with integrity. Emily is a talented executive who leads at the intersection of business strategy and financial discipline and thrives on solving complex, challenging problems.
Most recently, Emily was Chief Financial Officer of Orthofix, a publicly traded global medical device manufacturer and distributor in the spine and orthopedic markets. She was instrumental in designing and leading the turnaround strategy that stabilized the company through restructuring, eliminating unprofitable businesses, and strengthening internal controls. Throughout the turnaround, she maintained a strong cash position, healthy cash generation, and low debt balance. She also led the company through a financial restatement involving multiple fiscal years while avoiding NASDAQ delisting and default on the credit facility and ultimately bringing the company into SEC, NASDAQ, and credit facility compliance.
Previously as CFO of Orthofix’s Global Orthopedic Division, she directed international finance covering 7 locations in Europe, Latin America, and the U.S. In this role, she used an expense reduction strategy to transform an unprofitable business to profitable. Earlier, as Corporate Vice President and Controller, she was instrumental in the company's successful defense of a hostile shareholder proxy contest. Emily joined Orthofix as it became a U.S. Registrant with the SEC and in the inaugural year of Sarbanes-Oxley, where she was chartered with building an SEC function. Her early accounting career included roles with Eastman Chemical, Safety-Kleen, and two public accounting firms.
Contact Emily at: [email protected]
SVP, Finance and Accounting @ NorthStar Anesthesia is a leading national anesthesia management company that partners with approximately 150 hospitals and acute surgery centers to provide productive and efficient anesthesia care with a team of 1,600 providers in 19 states. From November 2014 to Present (1 year 2 months) Chief Financial Officer (CFO) @ Orthofix International N.V. is a $500 million global medical device manufacturer and distributor of products in the spine and orthopedic markets.
Entered the role as Interim CFO and promoted to CFO in April 2013. Reporting to the CEO, led team of 500 employees in financial strategy, accounting operations, financial planning and analysis, investor relations, treasury, tax, insurance billing, and information systems
• Maintained a strong cash position, healthy cash generation, low debt balance and substantially decreased Days Sales Outstanding (DSO’s) while executing a turnaround strategy
• Led company through multi-year financial restatement while navigating the requirements of the SEC, NASDAQ, & bank lenders, ensured renewal of D&O insurance, and avoided NASDAQ delisting and default on the credit facility
• Created, implemented, and communicated new financial metrics that resolved analyst/investor confusion about restructuring activities and garnered their support for the company
• Led the investor call following the restructure and restatement that was instrumental in a stock price increase of 25% as analysts gained confidence in the business and financial data
• Designed 3-year Long-Term Incentive Plan incorporating performance-based restricted shares that aligned with ISS standards of equity compensation plans
• Evaluated feasibility of redomiciling the company's tax residence and identified a potential savings of up to $14 million for Board consideration
• Drove organizational performance through talent development and management including targeted recruiting, training, and coaching that fostered an energetic and inspired team prepared to take on the challenges facing the company
• Built a culture within the Finance and IT organizations for solving complex problems using imperfect information balanced by decision making based on calculated risk From November 2012 to April 2014 (1 year 6 months) Chief Financial Officer, Global Orthopedics (Divisional CFO) @ Reporting to the President, Global Orthopedics, directed international finance function of $160 million division with 7 locations in Europe, Latin America, and the U.S. Led team of 50 professionals located globally.
• Instrumental in achieving an operating income increase of 32% in 2011 by developing a smaller footprint, high performance global finance team that drove disciplined growth, strengthened controls, and scaled the infrastructure for rapid scaling and long-term sustainability
• Drove sales volume increase of 11% in 2011 through collaboration with global sales leaders on the development of a real-time sales forecasting capability From August 2010 to April 2013 (2 years 9 months) Vice President, Controller @ Led corporate accounting, FP&A, and internal control functions including financial reporting, technical accounting research, tax, general accounting, and policies and procedures. Liaison to legal, human resources, Board of Directors Audit and Compensation Committees, and outside audit and valuation services.
• Improved the consolidation closing process, reducing monthly closing period by 5 days
• Saved $500,000 in annual expenditures by implementing company-wide travel program
• Implemented and ensured sound financial controls and policies and procedures for Sarbanes- Oxley 404 requirements across 26 global entities
• Participated in successful proxy contest against activist hedge fund
• Established the company’s focus on budgeting and forecasting on a “real time” basis
• Led the system implementation for stock option and employee stock purchase plans From June 2008 to July 2010 (2 years 2 months) Greater Boston AreaDirector of Finance/Manager Financial Reporting/Sr. SEC and Consolidations Accountant @ Joined Orthofix as it became a U.S. Registrant with the SEC and in the inaugural year of SOX 404
Chartered with building an SEC reporting function and bringing company into SOX 404 readiness and compliance
• Instrumental in 2 acquisitions and integrations of a $330 million spine medical device company and a $150 million sports medicine company, including securing related senior debt credit facilities
• Built and enhanced Corporate Accounting, Internal Controls, and Financial Reporting functions, providing an infrastructure that supported the company’s growth while progressing through roles of increasing responsibility
• Successfully established SEC reporting function and SOX 404 compliance during 2004 From July 2003 to June 2008 (5 years) Charlotte, North Carolina AreaSr. SEC Accountant @ From December 2002 to July 2003 (8 months) Financial Reporting Accountant @ From July 2001 to December 2002 (1 year 6 months) Columbia, South Carolina AreaSenior Accountant @ From July 1999 to July 2001 (2 years 1 month) Columbia, South Carolina AreaAccountant @ From March 1998 to July 1999 (1 year 5 months) Columbia, South Carolina Area
Bachelor of Arts, Accounting, cum laude @ Columbia College (SC) From 1995 to 1998 Emily Taylor is skilled in: Financial Strategy, Mergers & Acquisitions, Business Growth Strategies, Turnaround Strategy, Corporate Governance, Financial Operations, Executive Management, Crisis Management, Organizational Leadership, Acquisition Integration, Medical Devices, Information Technology, Strategic Financial Planning, Leading Development Teams, Leadership
Looking for a different
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension